Select a Region North America

Expertise

headshot of Alexander Hall

Alexandra Hall

Associate Manager, HEOR

Expertise:

Health Economic Research

Alex is an associate manager on the Value & Evidence team at EVERSANA and supports various projects in Health Economics and Outcomes Research (HEOR).

Since joining the team in 2021, Alex has been involved in systematic literature reviews, indirect treatment comparisons, peer-reviewed manuscripts and value communications materials, such as slide decks, value dossiers and briefs. She has gained experience in various therapeutic areas including oncology, dermatology, medical devices and psychology. ​

Alex’s academic training includes an MBS and MPH from the University of Guelph. Prior to joining EVERSANA, Alex worked at the Hospital for Sick Children focused on the development of pediatric reference intervals for biochemical and immunochemical markers. She has previously contributed and co-authored a number clinical and academic research peer-reviewed publications as well as scoping and targeted literature reviews. ​

Articles by Alexandra Hall

Cutting-edge Insights from EVERSANA's Global Value & Evidence Team
Enhancing Quality of Life in Advanced Breast Cancer: The Role of Palbociclib

Advanced breast cancer often comes with significant physical symptoms, such as pain and fatigue, as well as side effects from treatments. The diagnosis and treatment of advanced breast cancer can lead to anxiety, depression and stress. Improving a patient’s quality of life can help manage these symptoms more effectively, making daily life more bearable. Focusing on quality of life in the face of a challenging diagnosis has become a primary goal of breast cancer therapy, particularly in the advanced setting, where outcomes are often poor. Palbociclib, a first-in-class cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, received approval from the United States (U.S.) Food and Drug Administration in 2015 for the treatment of […]

Interested in scheduling a meeting or speaking event?

お問い合わせ